大博医疗: 2025年半年度业绩预告

Core Viewpoint - The company, Dabo Medical Technology Co., Ltd., is forecasting a significant increase in net profit for the first half of 2025, driven by product innovation and strategic international development [1][2]. Financial Performance Summary - The expected net profit for the reporting period (January 1, 2025, to June 30, 2025) is projected to be between 230 million to 250 million yuan, representing a year-on-year growth of approximately 66.37% to 80.84% [1][2]. - The net profit attributable to shareholders is expected to be between 230 million to 250 million yuan, compared to 138.24 million yuan in the same period last year [1]. - The basic earnings per share are forecasted to be between 0.5657 yuan to 0.6148 yuan, up from 0.3339 yuan per share in the previous year [1]. Business Development Factors - The company attributes its performance improvement to the new growth norm following the centralized procurement of consumables, alongside a commitment to product innovation and technical services [2]. - The company has incurred approximately 25 million yuan in equity payment expenses during the reporting period [2].